$79.5 Million is the total value of SABBY MANAGEMENT, LLC's 88 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 210.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | IONIS PHARMACEUTICALS INCcall | $17,809,000 | +1349.1% | 2,771 | +49.9% | 22.39% | +3695.1% | |
| New | AMARIN CORPORATION PLCput | $4,859,000 | – | 2,506 | +100.0% | 6.11% | – | |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $2,053,000 | – | 8,343,716 | +100.0% | 2.58% | – |
| AMPE | New | AMPIO PHARMACEUTICALS INC | $2,042,000 | – | 5,265,265 | +100.0% | 2.57% | – |
| CJJD | New | CHINA JO-JO DRUGSTORES INC | $2,010,000 | – | 1,827,203 | +100.0% | 2.53% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $1,937,000 | – | 494,175 | +100.0% | 2.44% | – |
| INNT | New | INNOVATE BIOPHARMACEUTICLS INC | $1,550,000 | – | 1,336,248 | +100.0% | 1.95% | – |
| SHIPW | New | SEANERGY MARITIME HOLDINGS CORP*w | $1,544,000 | – | 965,000 | +100.0% | 1.94% | – |
| New | DIFFUSION PHARMACEUTICALS INC | $1,336,000 | – | 468,620 | +100.0% | 1.68% | – | |
| PHAS | New | PHASEBIO PHARMACEUTICALS INC | $1,088,000 | – | 82,931 | +100.0% | 1.37% | – |
| SHIP | New | SEANERGY MARITIME HOLDINGS CORP | $1,032,000 | – | 1,669,941 | +100.0% | 1.30% | – |
| PULM | New | PULMATRIX INC | $984,000 | – | 1,067,209 | +100.0% | 1.24% | – |
| AVCO | New | AVALON GLOBOCARE CORP | $889,000 | – | 341,871 | +100.0% | 1.12% | – |
| GNPX | Buy | GENPREX INC | $798,000 | -12.4% | 643,295 | +9.9% | 1.00% | +129.0% |
| New | AVEO PHARMACEUTICALS INC COMput | $744,000 | – | 5,208 | +100.0% | 0.94% | – | |
| ALRN | New | AILERON THERAPEUTICS INC | $728,000 | – | 1,011,137 | +100.0% | 0.92% | – |
| Buy | CEL-SCI CORPput | $703,000 | +539.1% | 1,392 | +346.2% | 0.88% | +1567.9% | |
| VXRT | Buy | VAXART INC | $617,000 | +61.5% | 920,647 | +367.3% | 0.78% | +321.7% |
| OGEN | Buy | ORAGENICS INC | $617,000 | +106.4% | 1,259,333 | +146.6% | 0.78% | +438.9% |
| CANF | New | CAN FITE BIOPHARMA LTD | $610,000 | – | 211,896 | +100.0% | 0.77% | – |
| AMRN | New | AMARIN CORPORATION PLCadr | $609,000 | – | 31,433 | +100.0% | 0.77% | – |
| New | AURINIA PHARMACEUTICALS INCcall | $596,000 | – | 906 | +100.0% | 0.75% | – | |
| New | BRAINSTORM CELL THERAPEUTICS INCput | $532,000 | – | 1,990 | +100.0% | 0.67% | – | |
| SYN | Buy | SYNTHETIC BIOLOGICS INC | $497,000 | +6.9% | 903,741 | +31.9% | 0.62% | +180.3% |
| STOK | New | STOKE THERAPEUTICS INC | $473,000 | – | 16,202 | +100.0% | 0.60% | – |
| SLS | New | SELLAS LIFE SCIENCES GROUP INC | $442,000 | – | 3,926,022 | +100.0% | 0.56% | – |
| EMAN | New | EMAGIN CORP | $392,000 | – | 861,903 | +100.0% | 0.49% | – |
| Buy | ISHARES TRcall | $390,000 | -92.9% | 496 | +37.8% | 0.49% | -81.5% | |
| SCON | Buy | SUPERCONDUCTOR TECHNOLOGIES | $384,000 | -2.0% | 467,900 | +78.9% | 0.48% | +156.9% |
| CYTR | Buy | CYTRX CORP | $366,000 | -41.8% | 1,060,999 | +8.8% | 0.46% | +52.3% |
| EARS | New | AURIS MED HLDG LTD | $342,000 | – | 123,590 | +100.0% | 0.43% | – |
| RWLK | New | REWALK ROBOTICS LTD | $341,000 | – | 78,300 | +100.0% | 0.43% | – |
| NURO | Buy | NEUROMETRIX INC | $332,000 | -1.8% | 809,482 | +163.2% | 0.42% | +157.4% |
| Buy | ISHARES TRput | $275,000 | -99.2% | 2,556 | +15.3% | 0.35% | -97.9% | |
| BLIN | New | BRIDGELINE DIGITAL INC COM | $270,000 | – | 110,400 | +100.0% | 0.34% | – |
| HEB | New | HEMISPHERX BIOPHARMA INC | $267,000 | – | 60,858 | +100.0% | 0.34% | – |
| TMDI | New | TITAN MEDICAL INC | $265,000 | – | 112,305 | +100.0% | 0.33% | – |
| OPTT | New | OCEAN PWR TECHNOLOGIES INC | $228,000 | – | 119,312 | +100.0% | 0.29% | – |
| MDGSW | Buy | MEDIGUS LTD*w | $218,000 | -52.3% | 1,030,654 | +1.6% | 0.27% | +24.5% |
| RMTI | New | ROCKWELL MED INC | $217,000 | – | 72,059 | +100.0% | 0.27% | – |
| Buy | TITAN PHARMACEUTICALS INCput | $211,000 | +14.7% | 1,613 | +56.5% | 0.26% | +201.1% | |
| AVEO | New | AVEO PHARMACEUTICALS INC COM | $189,000 | – | 281,112 | +100.0% | 0.24% | – |
| SHIPZ | New | SEANERGY MARITIME HOLDINGS CORP*w | $178,000 | – | 888,889 | +100.0% | 0.22% | – |
| Buy | AETERNA ZENTARIS INCput | $137,000 | +13600.0% | 501 | +4075.0% | 0.17% | – | |
| APOP | Buy | CELLECT BIOTECHNOLOGY LTDads | $124,000 | -42.1% | 243,563 | +15.0% | 0.16% | +51.5% |
| ONTXW | Buy | ONCONOVA THERAPEUTICS INC*w | $115,000 | +228.6% | 642,312 | +0.1% | 0.14% | +752.9% |
| CALA | New | CALITHERA BIOSCIENCES INC | $112,000 | – | 28,806 | +100.0% | 0.14% | – |
| Buy | SPDR S&P BIOTECHput | $109,000 | -97.6% | 854 | +70.8% | 0.14% | -93.7% | |
| ADXS | New | ADVAXIS INC | $87,000 | – | 41,722 | +100.0% | 0.11% | – |
| ALT | New | ALTIMMUNE INC | $81,000 | – | 34,205 | +100.0% | 0.10% | – |
| Buy | APPLIED DNA SCIENCES INCput | $78,000 | +143.8% | 390 | +35.4% | 0.10% | +553.3% | |
| New | SESEN BIO INCput | $70,000 | – | 561 | +100.0% | 0.09% | – | |
| RKDA | New | ARCADIA BIOSCIENCES INC | $61,000 | – | 20,000 | +100.0% | 0.08% | – |
| CLSN | New | CELSION CORP | $56,000 | – | 31,000 | +100.0% | 0.07% | – |
| New | CEL-SCI CORPcall | $56,000 | – | 100 | +100.0% | 0.07% | – | |
| NSPR | New | INSPIREMD INC | $50,000 | – | 14,800 | +100.0% | 0.06% | – |
| SPHS | Buy | SOPHIRIS BIO INC | $45,000 | +36.4% | 52,685 | +56.6% | 0.06% | +256.2% |
| AEZS | New | AETERNA ZENTARIS INC | $38,000 | – | 12,799 | +100.0% | 0.05% | – |
| Buy | CELSION CORPcall | $23,000 | +15.0% | 129 | +29.0% | 0.03% | +190.0% | |
| New | ORAMED PHARMACEUTICALS INCcall | $17,000 | – | 489 | +100.0% | 0.02% | – | |
| KTOV | New | KITOV PHARMA LTDads | $14,000 | – | 14,500 | +100.0% | 0.02% | – |
| SINT | New | SINTX TECHNOLOGIES INC | $7,000 | – | 84,655 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.